A significant breakthrough in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This vital malignant suppressor protein is frequently inactivated in many forms of malignancies, causing https://bookmarklinx.com/story22011763/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-malignant-treatment